Pharmacogenetic Investigation of Efficacy Response to Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis
Rheumatology International - Germany
doi 10.1007/s00296-020-04523-6
Full Text
Open PDFAbstract
Available in full text
Date
February 3, 2020
Authors
Publisher
Springer Science and Business Media LLC